Preferences for daily or intermittent pre-exposure prophylaxis regimens and ability to anticipate sex among HIV uninfected members of Kenyan HIV serodiscordant couples

Sarah T. Roberts, Renee Heffron, Kenneth Ngure, Connie Celum, Ann Kurth, Kathryn Curran, Nelly Mugo, Jared M. Baeten

Research output: Contribution to journalArticle

Abstract

Intermittent dosing for pre-exposure prophylaxis (PrEP) has been proposed as an alternative to daily PrEP to reduce cost and patient drug exposure and to improve adherence. One possible dosing regimen is pre-intercourse PrEP, which requires anticipating sex in advance. We examined preferences for daily versus pre-intercourse PrEP and ability to anticipate sex among 310 HIV uninfected members of HIV serodiscordant heterosexual couples in Thika, Kenya, with high HIV knowledge and experience with daily PrEP use in a clinical trial setting. Preferences were evenly split between daily PrEP (47.4 %) and pre-intercourse PrEP (50.7 %). Participants were more likely to prefer daily PrEP if they reported unprotected sex during the prior month (adjusted prevalence ratio [aPR] 1.48, 95 % CI 1.20-1.81) or <80 % adherence to study drug (aPR 1.50, 95 % CI 1.25-1.79), and were less likely to prefer daily PrEP if sex was usually planned, versus spontaneous (aPR 0.76, 95 % CI 0.61-0.96). A minority (24.2 %) reported anticipating sex >3 h in advance, with younger participants being less likely to do so (aPR 0.43, 95 % CI 0.23-0.83 for ages 18-29 vs. ≥40). Findings suggest that intermittent PrEP could be a popular option in this population, but that optimal adherence and sufficient drug levels might be challenging with a pre-intercourse regimen.

Original languageEnglish (US)
Pages (from-to)1701-1711
Number of pages11
JournalAIDS and Behavior
Volume18
Issue number9
DOIs
StatePublished - 2014

Fingerprint

Aptitude
HIV
Unsafe Sex
Pre-Exposure Prophylaxis
Drug Costs
Kenya
Heterosexuality
Clinical Trials

Keywords

  • HIV serodiscordant couples
  • Intermittent pre-exposure prophylaxis (iPrEP)
  • Kenya
  • Pre-exposure prophylaxis (PrEP)
  • Sexual behavior

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases
  • Social Psychology
  • Medicine(all)

Cite this

Preferences for daily or intermittent pre-exposure prophylaxis regimens and ability to anticipate sex among HIV uninfected members of Kenyan HIV serodiscordant couples. / Roberts, Sarah T.; Heffron, Renee; Ngure, Kenneth; Celum, Connie; Kurth, Ann; Curran, Kathryn; Mugo, Nelly; Baeten, Jared M.

In: AIDS and Behavior, Vol. 18, No. 9, 2014, p. 1701-1711.

Research output: Contribution to journalArticle

Roberts, Sarah T. ; Heffron, Renee ; Ngure, Kenneth ; Celum, Connie ; Kurth, Ann ; Curran, Kathryn ; Mugo, Nelly ; Baeten, Jared M. / Preferences for daily or intermittent pre-exposure prophylaxis regimens and ability to anticipate sex among HIV uninfected members of Kenyan HIV serodiscordant couples. In: AIDS and Behavior. 2014 ; Vol. 18, No. 9. pp. 1701-1711.
@article{5304d52fb35548f383e16bf354088dbb,
title = "Preferences for daily or intermittent pre-exposure prophylaxis regimens and ability to anticipate sex among HIV uninfected members of Kenyan HIV serodiscordant couples",
abstract = "Intermittent dosing for pre-exposure prophylaxis (PrEP) has been proposed as an alternative to daily PrEP to reduce cost and patient drug exposure and to improve adherence. One possible dosing regimen is pre-intercourse PrEP, which requires anticipating sex in advance. We examined preferences for daily versus pre-intercourse PrEP and ability to anticipate sex among 310 HIV uninfected members of HIV serodiscordant heterosexual couples in Thika, Kenya, with high HIV knowledge and experience with daily PrEP use in a clinical trial setting. Preferences were evenly split between daily PrEP (47.4 {\%}) and pre-intercourse PrEP (50.7 {\%}). Participants were more likely to prefer daily PrEP if they reported unprotected sex during the prior month (adjusted prevalence ratio [aPR] 1.48, 95 {\%} CI 1.20-1.81) or <80 {\%} adherence to study drug (aPR 1.50, 95 {\%} CI 1.25-1.79), and were less likely to prefer daily PrEP if sex was usually planned, versus spontaneous (aPR 0.76, 95 {\%} CI 0.61-0.96). A minority (24.2 {\%}) reported anticipating sex >3 h in advance, with younger participants being less likely to do so (aPR 0.43, 95 {\%} CI 0.23-0.83 for ages 18-29 vs. ≥40). Findings suggest that intermittent PrEP could be a popular option in this population, but that optimal adherence and sufficient drug levels might be challenging with a pre-intercourse regimen.",
keywords = "HIV serodiscordant couples, Intermittent pre-exposure prophylaxis (iPrEP), Kenya, Pre-exposure prophylaxis (PrEP), Sexual behavior",
author = "Roberts, {Sarah T.} and Renee Heffron and Kenneth Ngure and Connie Celum and Ann Kurth and Kathryn Curran and Nelly Mugo and Baeten, {Jared M.}",
year = "2014",
doi = "10.1007/s10461-014-0804-1",
language = "English (US)",
volume = "18",
pages = "1701--1711",
journal = "AIDS and Behavior",
issn = "1090-7165",
publisher = "Springer New York",
number = "9",

}

TY - JOUR

T1 - Preferences for daily or intermittent pre-exposure prophylaxis regimens and ability to anticipate sex among HIV uninfected members of Kenyan HIV serodiscordant couples

AU - Roberts, Sarah T.

AU - Heffron, Renee

AU - Ngure, Kenneth

AU - Celum, Connie

AU - Kurth, Ann

AU - Curran, Kathryn

AU - Mugo, Nelly

AU - Baeten, Jared M.

PY - 2014

Y1 - 2014

N2 - Intermittent dosing for pre-exposure prophylaxis (PrEP) has been proposed as an alternative to daily PrEP to reduce cost and patient drug exposure and to improve adherence. One possible dosing regimen is pre-intercourse PrEP, which requires anticipating sex in advance. We examined preferences for daily versus pre-intercourse PrEP and ability to anticipate sex among 310 HIV uninfected members of HIV serodiscordant heterosexual couples in Thika, Kenya, with high HIV knowledge and experience with daily PrEP use in a clinical trial setting. Preferences were evenly split between daily PrEP (47.4 %) and pre-intercourse PrEP (50.7 %). Participants were more likely to prefer daily PrEP if they reported unprotected sex during the prior month (adjusted prevalence ratio [aPR] 1.48, 95 % CI 1.20-1.81) or <80 % adherence to study drug (aPR 1.50, 95 % CI 1.25-1.79), and were less likely to prefer daily PrEP if sex was usually planned, versus spontaneous (aPR 0.76, 95 % CI 0.61-0.96). A minority (24.2 %) reported anticipating sex >3 h in advance, with younger participants being less likely to do so (aPR 0.43, 95 % CI 0.23-0.83 for ages 18-29 vs. ≥40). Findings suggest that intermittent PrEP could be a popular option in this population, but that optimal adherence and sufficient drug levels might be challenging with a pre-intercourse regimen.

AB - Intermittent dosing for pre-exposure prophylaxis (PrEP) has been proposed as an alternative to daily PrEP to reduce cost and patient drug exposure and to improve adherence. One possible dosing regimen is pre-intercourse PrEP, which requires anticipating sex in advance. We examined preferences for daily versus pre-intercourse PrEP and ability to anticipate sex among 310 HIV uninfected members of HIV serodiscordant heterosexual couples in Thika, Kenya, with high HIV knowledge and experience with daily PrEP use in a clinical trial setting. Preferences were evenly split between daily PrEP (47.4 %) and pre-intercourse PrEP (50.7 %). Participants were more likely to prefer daily PrEP if they reported unprotected sex during the prior month (adjusted prevalence ratio [aPR] 1.48, 95 % CI 1.20-1.81) or <80 % adherence to study drug (aPR 1.50, 95 % CI 1.25-1.79), and were less likely to prefer daily PrEP if sex was usually planned, versus spontaneous (aPR 0.76, 95 % CI 0.61-0.96). A minority (24.2 %) reported anticipating sex >3 h in advance, with younger participants being less likely to do so (aPR 0.43, 95 % CI 0.23-0.83 for ages 18-29 vs. ≥40). Findings suggest that intermittent PrEP could be a popular option in this population, but that optimal adherence and sufficient drug levels might be challenging with a pre-intercourse regimen.

KW - HIV serodiscordant couples

KW - Intermittent pre-exposure prophylaxis (iPrEP)

KW - Kenya

KW - Pre-exposure prophylaxis (PrEP)

KW - Sexual behavior

UR - http://www.scopus.com/inward/record.url?scp=84906310242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906310242&partnerID=8YFLogxK

U2 - 10.1007/s10461-014-0804-1

DO - 10.1007/s10461-014-0804-1

M3 - Article

VL - 18

SP - 1701

EP - 1711

JO - AIDS and Behavior

JF - AIDS and Behavior

SN - 1090-7165

IS - 9

ER -